Biopharma

Novartis Receives Third FDA Approval for Oral Fabhalta ...

Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) ...

FDA Approves Tremfya (guselkumab) for Adult Patients wi...

HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced th...

Alnylam Announces FDA Approval of Amvuttra (vutrisiran)...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 20, 2025-- Alnylam Pharmaceuticals, Inc....

FDA Approves Pembrolizumab for HER2 Positive Gastric or...

On March 19, 2025, the Food and Drug Administration granted traditional approval...

STAT+: Former FDA commissioner Scott Gottlieb questions...

Trump's former FDA commissioner criticized the current administration's approach...

AstraZeneca enters license agreement with Alteogen

AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement f...

Roche enters into an exclusive collaboration & licensin...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has entered into an exclusi...

STAT+: Former CDC director Tom Frieden shares warning f...

Wavering on vaccines and slashing public health spending could allow the Texas o...

Keeping fit and building muscle could increase survival...

Physical fitness and increasing muscle strength could reduce the mortality rate ...

Continued medication important for heart failure patients

Patients who have been treated for heart failure and experience an improvement o...

Newly identified bacterial protein helps design cancer ...

A previously unknown protein in a family of bacteria found in soil and the human...

Almost 3.6 Million Births Recorded in 2023, Down 2 Perc...

FRIDAY, March 21, 2025 -- The total number of births in the United States in 20...

Chimerix engaged with 7 other biopharmas before choosin...

Before Jazz Pharmaceuticals inked a $935 million deal for Chimerix, the biotech ...

Optum Rx is reforming how it pays pharmacies

The PBM is pivoting to a cost-based reimbursement model, which it says will redu...

FDA Roundup: March 21, 2025

The U.S. Food and Drug Administration is providing an at-a-glance summary of new...

FDA rejects Hengrui, Elevar's PD-1 cancer drug combinat...

The FDA has once again issued a complete response letter to Hengrui and Elevar’s...

#FierceMadness: The 2025 Drug Ad Tournament heats up in...

As the college basketball March Madness tournament gets underway, so too does Fi...

UPDATE: Adaptimmune, after bringing cell therapy to mar...

Despite a historic FDA approval last year, Adaptimmune Therapeutics is expressin...

Low-Dose Doxycycline Effective for Lymphocytic Scarring...

FRIDAY, March 21, 2025 – Relative to high-dose doxycycline, low-dose doxycyclin...

Low-Glucose Alerts Beneficial for Insulin-Treated Drive...

FRIDAY, March 21, 2025 -- For individuals with type 1 diabetes, low-glucose ale...

Specific Dietary Elements Linked to Reduced Incidence o...

FRIDAY, March 21, 2025 -- Specific dietary elements, including fruit, dietary f...

Microplastics Found in Filtered Solutions Used for Medi...

FRIDAY, March 21, 2025 -- Microplastics appear to be present in filtered soluti...

Denoised Ultra-Low-Dose CT Better for Identifying Lungs...

FRIDAY, March 21, 2025 -- For individuals who are immunocompromised, denoised u...

Food Insecurity Tied to Incident Cardiovascular Disease...

FRIDAY, March 21, 2025 -- Food insecurity is associated with incident cardiovas...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.